<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=896170837107954&amp;ev=PageView&amp;noscript=1">

Teleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*

Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for Patients with Enlarged Prostate

Read More

Teleflex Celebrates 175,000 Patients Treated with the UroLift® System

Minimally Invasive Treatment for Enlarged Prostate Provides Rapid Relief1 and Durable Results2

WAYNE, Pa.— March 11, 2020—Teleflex Incorporated (NYSE: TFX) today announced that 175,000 patients have now been treated globally* with its minimally invasive UroLift® System—a safe and effective treatment for Benign Prostatic Hyperplasia (BPH) that provides rapid symptom relief and improved quality of life, while preserving sexual function.**1,3

BPH, also known as enlarged prostate, is a non-cancerous enlargement of the prostate that occurs as men age. This common condition is marked by bothersome urinary symptoms, such as getting up frequently at night to urinate, that can lead to loss of productivity, depression, and decreased quality of life.4 BPH affects over 40 million men in the United States alone.5 If left untreated, the condition can worsen over time and cause permanent bladder damage.6

Read More

Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and Effective Symptom Relief.

Read More

Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate

Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication

Read More

Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System

Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population

Read More

Teleflex Announces Expanded Nationwide Coverage for the UroLift System for Patients with Enlarged Prostate

Coverage Decision by Anthem Increases Access to Minimally Invasive Treatment, Offering Patients Rapid, Durable Symptom Relief

Read More

Teleflex Announces Positive Results from Five Studies Underscoring the Effectiveness and Versatility of the UroLift® System Treatment for BPH

Real-World Data Presented at American Urological Association Meeting Highlight Consistency with Controlled Studies and Effectiveness in Diverse Patient Populations

Read More

Teleflex Announces Multiple Data Presentations from Studies of the UroLift® System Treatment for Enlarged Prostate at the American Urological Association 2019 Meeting

Data featuring real-world findings in a large, multi-center study, and effectiveness and sexual function preservation in diverse patient populations to be presented at the Annual Meeting of the American Urological Association
Read More

Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate

Findings Presented at European Association of Urology Show Consistent Positive Results for Minimally Invasive UroLift System Treatment  

Read More

NeoTract Announces 100,000 Patients Treated for Enlarged Prostate with UroLift® System

Minimally Invasive UroLift System Treatment Provides Rapid Symptom Relief and Improved Quality of Life, While Preserving Sexual Function*1,2

Read More